drugset / Trial / NCT06861413
A Phase 1 Study to Evaluate the Relative Bioavailability of a VX-828 Tablet Formulation
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the relative bioavailability of a VX-828 tablet formulation compared to a suspension and evaluate its safety and tolerability.
Timeline
- Start
- 2025-04-01
- Primary completion
- 2025-05-05
- Completion
- 2025-05-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | VX-828 | Unknown | — | Oral |